Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug
Schizophrenia is a chronic and severe mental disorder affecting 20 million people worldwide. Research has not identified the causes of schizophrenia as one single factor. It is thought that interactions between genes and a range of environmental factors may cause schizophrenia. The majority of schiz...
Gespeichert in:
| Veröffentlicht in: | Organic process research & development 2022-03, Vol.26 (3), p.493-507 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 507 |
|---|---|
| container_issue | 3 |
| container_start_page | 493 |
| container_title | Organic process research & development |
| container_volume | 26 |
| creator | Bhosle, Siddhanath D Itage, Shivanand V Gangapuram, Balraju Eppa, Gyanchander Bhosale, Rajesh S Yadav, Jhillu Singh |
| description | Schizophrenia is a chronic and severe mental disorder affecting 20 million people worldwide. Research has not identified the causes of schizophrenia as one single factor. It is thought that interactions between genes and a range of environmental factors may cause schizophrenia. The majority of schizophrenia cases are controlled by the use of antipsychotic drugs, such as aripiprazole, asenapine, olanzapine, quetiapine, risperidone, and cariprazine. Gedeon Richter and Forest Laboratories developed an antipsychotic drug known as cariprazine that contains a piperazine ring, and it is manufactured by Actavis under the trade name Vraylar. This review provides a brief background of the synthetic approaches to cariprazine. |
| doi_str_mv | 10.1021/acs.oprd.1c00488 |
| format | Article |
| fullrecord | <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_acs_oprd_1c00488</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>a733944135</sourcerecordid><originalsourceid>FETCH-LOGICAL-a280t-e54fef3c647ad72360e33086cda872cff12288a4c2854bef9dce9d3ade6301653</originalsourceid><addsrcrecordid>eNp1kFtLwzAUx4MoOKfvPuYDrPUkadPsccwrDAQvoE_lmIvL0KYknaN-elu2V5_OH_4XDj9CLhnkDDi7Qp3y0EaTMw1QKHVEJqzkkJVKvh0PGpTIJJNwSs5S2gBAKRmfkPcn--PtjgZHn_umW9vOa7po2xhQr22iXdhhNHQwDn7yaQwvMfo24q9v7IxiQxdN59vU63UYB67j9vOcnDj8SvbicKfk9fbmZXmfrR7vHpaLVYZcQZfZsnDWCS2LCk3FhQQrBCipDaqKa-cY50phobkqiw_r5kbbuRForBTAZCmmBPa7OoaUonV1G_03xr5mUI9o6gFNPaKpD2iGymxfGZ1N2MZmePD_-B-QnWmd</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug</title><source>American Chemical Society Journals</source><creator>Bhosle, Siddhanath D ; Itage, Shivanand V ; Gangapuram, Balraju ; Eppa, Gyanchander ; Bhosale, Rajesh S ; Yadav, Jhillu Singh</creator><creatorcontrib>Bhosle, Siddhanath D ; Itage, Shivanand V ; Gangapuram, Balraju ; Eppa, Gyanchander ; Bhosale, Rajesh S ; Yadav, Jhillu Singh</creatorcontrib><description>Schizophrenia is a chronic and severe mental disorder affecting 20 million people worldwide. Research has not identified the causes of schizophrenia as one single factor. It is thought that interactions between genes and a range of environmental factors may cause schizophrenia. The majority of schizophrenia cases are controlled by the use of antipsychotic drugs, such as aripiprazole, asenapine, olanzapine, quetiapine, risperidone, and cariprazine. Gedeon Richter and Forest Laboratories developed an antipsychotic drug known as cariprazine that contains a piperazine ring, and it is manufactured by Actavis under the trade name Vraylar. This review provides a brief background of the synthetic approaches to cariprazine.</description><identifier>ISSN: 1083-6160</identifier><identifier>EISSN: 1520-586X</identifier><identifier>DOI: 10.1021/acs.oprd.1c00488</identifier><language>eng</language><publisher>American Chemical Society</publisher><ispartof>Organic process research & development, 2022-03, Vol.26 (3), p.493-507</ispartof><rights>2022 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a280t-e54fef3c647ad72360e33086cda872cff12288a4c2854bef9dce9d3ade6301653</citedby><cites>FETCH-LOGICAL-a280t-e54fef3c647ad72360e33086cda872cff12288a4c2854bef9dce9d3ade6301653</cites><orcidid>0000-0002-6535-1704</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.oprd.1c00488$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.oprd.1c00488$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids></links><search><creatorcontrib>Bhosle, Siddhanath D</creatorcontrib><creatorcontrib>Itage, Shivanand V</creatorcontrib><creatorcontrib>Gangapuram, Balraju</creatorcontrib><creatorcontrib>Eppa, Gyanchander</creatorcontrib><creatorcontrib>Bhosale, Rajesh S</creatorcontrib><creatorcontrib>Yadav, Jhillu Singh</creatorcontrib><title>Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug</title><title>Organic process research & development</title><addtitle>Org. Process Res. Dev</addtitle><description>Schizophrenia is a chronic and severe mental disorder affecting 20 million people worldwide. Research has not identified the causes of schizophrenia as one single factor. It is thought that interactions between genes and a range of environmental factors may cause schizophrenia. The majority of schizophrenia cases are controlled by the use of antipsychotic drugs, such as aripiprazole, asenapine, olanzapine, quetiapine, risperidone, and cariprazine. Gedeon Richter and Forest Laboratories developed an antipsychotic drug known as cariprazine that contains a piperazine ring, and it is manufactured by Actavis under the trade name Vraylar. This review provides a brief background of the synthetic approaches to cariprazine.</description><issn>1083-6160</issn><issn>1520-586X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kFtLwzAUx4MoOKfvPuYDrPUkadPsccwrDAQvoE_lmIvL0KYknaN-elu2V5_OH_4XDj9CLhnkDDi7Qp3y0EaTMw1QKHVEJqzkkJVKvh0PGpTIJJNwSs5S2gBAKRmfkPcn--PtjgZHn_umW9vOa7po2xhQr22iXdhhNHQwDn7yaQwvMfo24q9v7IxiQxdN59vU63UYB67j9vOcnDj8SvbicKfk9fbmZXmfrR7vHpaLVYZcQZfZsnDWCS2LCk3FhQQrBCipDaqKa-cY50phobkqiw_r5kbbuRForBTAZCmmBPa7OoaUonV1G_03xr5mUI9o6gFNPaKpD2iGymxfGZ1N2MZmePD_-B-QnWmd</recordid><startdate>20220318</startdate><enddate>20220318</enddate><creator>Bhosle, Siddhanath D</creator><creator>Itage, Shivanand V</creator><creator>Gangapuram, Balraju</creator><creator>Eppa, Gyanchander</creator><creator>Bhosale, Rajesh S</creator><creator>Yadav, Jhillu Singh</creator><general>American Chemical Society</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-6535-1704</orcidid></search><sort><creationdate>20220318</creationdate><title>Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug</title><author>Bhosle, Siddhanath D ; Itage, Shivanand V ; Gangapuram, Balraju ; Eppa, Gyanchander ; Bhosale, Rajesh S ; Yadav, Jhillu Singh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a280t-e54fef3c647ad72360e33086cda872cff12288a4c2854bef9dce9d3ade6301653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhosle, Siddhanath D</creatorcontrib><creatorcontrib>Itage, Shivanand V</creatorcontrib><creatorcontrib>Gangapuram, Balraju</creatorcontrib><creatorcontrib>Eppa, Gyanchander</creatorcontrib><creatorcontrib>Bhosale, Rajesh S</creatorcontrib><creatorcontrib>Yadav, Jhillu Singh</creatorcontrib><collection>CrossRef</collection><jtitle>Organic process research & development</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhosle, Siddhanath D</au><au>Itage, Shivanand V</au><au>Gangapuram, Balraju</au><au>Eppa, Gyanchander</au><au>Bhosale, Rajesh S</au><au>Yadav, Jhillu Singh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug</atitle><jtitle>Organic process research & development</jtitle><addtitle>Org. Process Res. Dev</addtitle><date>2022-03-18</date><risdate>2022</risdate><volume>26</volume><issue>3</issue><spage>493</spage><epage>507</epage><pages>493-507</pages><issn>1083-6160</issn><eissn>1520-586X</eissn><abstract>Schizophrenia is a chronic and severe mental disorder affecting 20 million people worldwide. Research has not identified the causes of schizophrenia as one single factor. It is thought that interactions between genes and a range of environmental factors may cause schizophrenia. The majority of schizophrenia cases are controlled by the use of antipsychotic drugs, such as aripiprazole, asenapine, olanzapine, quetiapine, risperidone, and cariprazine. Gedeon Richter and Forest Laboratories developed an antipsychotic drug known as cariprazine that contains a piperazine ring, and it is manufactured by Actavis under the trade name Vraylar. This review provides a brief background of the synthetic approaches to cariprazine.</abstract><pub>American Chemical Society</pub><doi>10.1021/acs.oprd.1c00488</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-6535-1704</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1083-6160 |
| ispartof | Organic process research & development, 2022-03, Vol.26 (3), p.493-507 |
| issn | 1083-6160 1520-586X |
| language | eng |
| recordid | cdi_crossref_primary_10_1021_acs_oprd_1c00488 |
| source | American Chemical Society Journals |
| title | Review of Synthetic Approaches toward the Synthesis of Cariprazine, an Antipsychotic Drug |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T21%3A20%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20of%20Synthetic%20Approaches%20toward%20the%20Synthesis%20of%20Cariprazine,%20an%20Antipsychotic%20Drug&rft.jtitle=Organic%20process%20research%20&%20development&rft.au=Bhosle,%20Siddhanath%20D&rft.date=2022-03-18&rft.volume=26&rft.issue=3&rft.spage=493&rft.epage=507&rft.pages=493-507&rft.issn=1083-6160&rft.eissn=1520-586X&rft_id=info:doi/10.1021/acs.oprd.1c00488&rft_dat=%3Cacs_cross%3Ea733944135%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |